Latest Breast cancer treatment Stories
A new study published in The Oncologist shows targeting both hormone receptors (HRs) and human epidermal growth factor receptor 2 (HER2) in first-line treatment of metastatic breast cancer (MBC)
Cianna Medical, Inc.: Researchers from 12 sites report favorably low recurrence rates and minimal toxicities. CHICAGO (PRWEB) May 02, 2013 Strut-based
Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumor, and with fewer serious side-effects to the surrounding normal organs.
Mathematical prediction models are better than doctors at predicting the outcomes and responses of lung cancer patients to treatment.
Treating early breast cancer patients with an advanced form of radiotherapy known as IMRT could reduce the side effects those women experience, according to the results of a randomized trial presented Sunday during the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) in Geneva, Switzerland.
Two landmark radiotherapy studies demonstrating cervical cancer tumors can be effectively treated with specifically-adapted high doses will be presented this weekend at the 2nd Forum of the European Society for Radiotherapy and Oncology.
For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment.
Cianna Medical, Inc: Recent studies conclude breast brachytherapy with the SAVI applicator appears to be a well-tolerated, effective treatment for early-stage breast cancer. New
- An imitative word; an onomatopoetic word.